Up to 20% of Population May Have Undiagnosed Mast Cell Activation Syndrome
"Up to 17 to 20% of the population may have mast cell syndrome and not know it. It mimics dozens of other conditions: allergies, IBS, anxiety, chronic fatigue, skin issues."
About this episode
Host Gary Brecka interviewed Dr. Tanya Dempsey, a Johns Hopkins-trained internal medicine physician and integrative medicine specialist, for an in-depth exploration of mast cell activation syndrome (MCAS), a widely underdiagnosed chronic inflammatory condition affecting up to 20% of the population. Dr. Dempsey, who runs the AIM Center for Personalized Medicine in Westchester County, New York, revealed that MCAS mimics dozens of other conditions including IBS, chronic fatigue, allergies, POTS, and fibromyalgia, causing patients to be misdiagnosed for years. Most controversially, she stated that 100% of her PCOS patients also have MCAS, suggesting the two conditions are fundamentally the same. The conversation explored how dysfunctional mast cells—immune system cells that manufacture over 1,200 different chemical mediators—become chronically activated by triggers including mold, heavy metals, Lyme disease, Epstein-Barr virus reactivation, and other infections. Dr. Dempsey explained her diagnostic approach using specialized blood and urine testing in her on-site laboratory, and detailed treatment protocols including supportive oligonucleotide technique (SOT) therapy that creates targeted synthetic RNA to neutralize specific pathogens. She also discussed therapeutic plasma exchange for detoxification, finding that patients show reduced levels of forever chemicals, BPA, and PFAS post-treatment. The physician reported finding Cryptosporidium—a parasite once limited to AIDS patients—in 75% of her patients, indicating severe immune suppression is far more widespread than conventional medicine recognizes. Brecka shared his daughter's experience with POTS and Ehlers-Danlos syndrome, which responded to mold remediation and heavy metal detox, likely addressing undiagnosed MCAS. Both agreed that chronic low-grade infections and environmental toxicity are at the root of most chronic disease, with the gut microbiome playing a central role. Dr. Dempsey emphasized personalized protocols including antimicrobial drugs, herbal treatments, peptides like thymosin alpha-1, GLP-1 receptor agonists which directly stabilize mast cells, red light therapy, and careful management of diet and supplements tailored to each patient's tolerance. The episode concluded with Dr. Dempsey calling MCAS a pandemic-level health crisis that conventional medicine continues to overlook.
Key takeaways
- Dr. Dempsey stated that 100% of her PCOS patients have mast cell activation syndrome, suggesting the conditions are the same underlying disorder.
- Up to 20% of the population may have undiagnosed MCAS, which mimics IBS, chronic fatigue, allergies, POTS, and fibromyalgia.
- Dr. Dempsey dismissed IBS as a legitimate condition, calling it a mast cell-driven phenomenon rather than a functional disorder.
- SOT therapy uses targeted synthetic RNA to directly bind and kill specific viruses, bacteria, and parasites without broad antimicrobials.
- Dr. Dempsey finds Cryptosporidium parasite in 75% of patients, indicating widespread immune suppression comparable to AIDS patients.
- GLP-1 receptor agonists like semaglutide and tirzepatide directly stabilize mast cells by binding to receptors on their surface.
- Therapeutic plasma exchange effectively removes forever chemicals, microplastics, BPA, and biofilm from blood according to pre-post testing.